Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 5,077-5,088 of 5,650
Drug study icon
RecruitingNCT04984512

Mitizodone Phosphate Tablets for depression

This study is recruiting in China. It is testing mitizodone Phosphate Tablets for depression.

In Dongguan
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
China
Sponsor
Sunshine Lake Pharma Co., Ltd.
Condition
Depression
Behavioral study icon
RecruitingNCT07644338

Temporal Interference Stimulation for PTSD

This study is recruiting in China. It is testing temporal Interference Stimulation for PTSD.

In Shanghai
PTSDBehavioralFrom 18 Years to 50 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
PTSD
Behavioral study icon
RecruitingISRCTN17220814

The efficacy of cognitive remediation on processing speed in people with first episode psychosis

This study is looking at whether a digital support tool can help people with Psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.

In Malaysia
SchizophreniaOtherOver 18 Years
Countries
Malaysia
Sponsor
Public Service Department of Malaysia
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN85501054

The efficacy of nutraceuticals in the treatment of chronic insomnia

This observational study is following people with Treatment of suffering from chronic insomnia and anxiety states or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Italy
AnxietyOtherFrom 18 Years to 75 Years
Countries
Italy
Sponsor
Sapienza University of Rome
Condition
Anxiety
Drug study icon
RecruitingISRCTN59554792

The efficacy of xanomeline-trospium in treating cognitive impairment in people with a psychotic disorder

This study is testing a medication approach for people with Schizophrenia, schizoaffective disorder, or schizophreniform disorder or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN95266816

The emergence of personality disorder traits in adolescents who deliberately Suicide prevention and the potential for using a mentalisation based treatment approach as an early intervention for such individuals: a controlled study

This study is recruiting in the United Kingdom. It focuses on Suicide prevention.

In United Kingdom
SuicidalityOtherFrom 13 Years to 18 Years
Countries
United Kingdom
Sponsor
North East London Mental Health Trust (NELMHT) (UK)
Condition
Suicidality
Behavioral study icon
RecruitingISRCTN34757603

The EPOS study: effective patient-clinician communication in community mental health care

This study is looking at how cognitive behavioural therapy works for people with Schizophrenia or Mental and Behavioural Disorders in routine care. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In United Kingdom
SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Queen Mary University of London (UK)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.